What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Enzyme
Kenji Hashimoto spends much of his time researching Internal medicine, Endocrinology, Pharmacology, NMDA receptor and Neuroscience.
His work in Internal medicine covers topics such as Anesthesia which are related to areas like Dopamine.
The Endocrinology study combines topics in areas such as Glutamine, Schizophrenia, Psychosis and Autism.
The study incorporates disciplines such as Fluvoxamine, Receptor, Phencyclidine, Antidepressant and Receptor antagonist in addition to Pharmacology.
His Antidepressant research integrates issues from Ketamine, Major depressive disorder and Social defeat.
He has included themes like Glutamate receptor, Glutamatergic, Glycine and Antagonist in his NMDA receptor study.
His most cited work include:
- Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. (938 citations)
- Calcium signals: the lead currency of plant information processing (682 citations)
- Nervous system involvement after infection with COVID-19 and other coronaviruses (679 citations)
What are the main themes of his work throughout his whole career to date?
Kenji Hashimoto mainly investigates Internal medicine, Endocrinology, Pharmacology, NMDA receptor and Schizophrenia.
His Internal medicine research is multidisciplinary, relying on both Neuroscience and Oncology.
His Endocrinology study often links to related topics such as Prefrontal cortex.
His studies examine the connections between Pharmacology and genetics, as well as such issues in Antidepressant, with regards to Social defeat.
His studies in NMDA receptor integrate themes in fields like Glutamate receptor, Glycine and Retrosplenial cortex.
His study on Schizophrenia is covered under Psychiatry.
He most often published in these fields:
- Internal medicine (32.76%)
- Endocrinology (27.14%)
- Pharmacology (25.43%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (32.76%)
- Endocrinology (27.14%)
- Pharmacology (25.43%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Endocrinology, Pharmacology, Antidepressant and Ketamine.
His biological study spans a wide range of topics, including Schizophrenia and Oncology.
His Endocrinology research incorporates elements of Offspring, Gut flora, Prefrontal cortex and Tropomyosin receptor kinase B.
His Pharmacology study combines topics from a wide range of disciplines, such as Tail suspension test, Potency, AMPA receptor, Dopamine and Receptor antagonist.
His research in Antidepressant intersects with topics in Receptor and Social defeat.
The concepts of his Ketamine study are interwoven with issues in NMDA receptor, Behavioural despair test, Antagonist, Metabolite and Depression.
Between 2016 and 2021, his most popular works were:
- Nervous system involvement after infection with COVID-19 and other coronaviruses (679 citations)
- Vicarious traumatization in the general public, members, and non-members of medical teams aiding in COVID-19 control (332 citations)
- Antidepressant Potential of (R)-Ketamine in Rodent Models: Comparison with (S)-Ketamine. (112 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Enzyme
His primary areas of investigation include Pharmacology, Antidepressant, Ketamine, Internal medicine and Endocrinology.
His study in Pharmacology is interdisciplinary in nature, drawing from both AMPA receptor, Fluoxetine, Serotonin, Depression and Receptor antagonist.
His Antidepressant research focuses on Social defeat and how it relates to Gut flora, Receptor, Prefrontal cortex, Pharmacokinetics and Psychological resilience.
His Ketamine research is multidisciplinary, incorporating elements of NMDA receptor, Antagonist, Potency, Metabolite and Metabolism.
His research integrates issues of TOR Serine-Threonine Kinases, Mechanistic target of rapamycin and MAPK/ERK pathway in his study of Internal medicine.
He has researched Endocrinology in several fields, including Offspring, Schizophrenia, Sulforaphane, Juvenile and Brain-derived neurotrophic factor.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
